Benzinga | Nov 10, 2021 05:59PM EST

Histogen Q3 EPS $(0.09) Beats $(0.11) Estimate, Sales $591.00K Up From $495.00K YoY

Histogen (NASDAQ:HSTO) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 66.67 percent increase over losses of $(0.27) per share from the same period last year. The company reported $591.00 thousand in sales this quarter. This is a 19.39 percent increase over sales of $495.00 thousand the same period last year.